(Q28266806)

2

Christian Mottet

0 references

Florian Froehlich

8

Florian Froehlich

0 references

Pierre Michetti

1

Pierre Michetti

0 references

Pascal Juillerat

3

Pascal Juillerat

0 references

Christian Felley

5

Christian Felley

0 references

John Paul Vader

6

John-Paul Vader

0 references

Jean-Jacques Gonvers

7

Management of Crohn's disease in adults

Jean-Jacques Gonvers

0 references

language of work or name

English

0 references

publication date

2007

0 references

published in

Digestion

0 references

volume

76

0 references

issue

2

0 references

page(s)

99-108

0 references

cites work

1 reference

Severe and steroid-resistant Crohn's disease.

21 January 2018

1 reference

Frequency of glucocorticoid resistance and dependency in Crohn's disease

21 January 2018

1 reference

Nutrition and inflammatory bowel disease

21 January 2018

1 reference

Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2).

21 January 2018

1 reference

A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

21 January 2018

1 reference

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

21 January 2018

1 reference

Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children.

21 January 2018

1 reference

Clinical trials evaluating endoscopic GERD treatments: is it time for a moratorium on the clinical use of these procedures?

21 January 2018

1 reference

Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial

21 January 2018

1 reference

Intravenous hydrocortisone premedication reduces antibodies to infliximab in Crohn's disease: a randomized controlled trial

21 January 2018

1 reference

Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial

21 January 2018

1 reference

Adalimumab induction therapy for Crohn disease previously treated with infliximab: a randomized trial

21 January 2018

1 reference

Intravenous CDP870, a PEGylated Fab' fragment of a humanized antitumour necrosis factor antibody, in patients with moderate-to-severe Crohn's disease: an exploratory study

21 January 2018

1 reference

A randomized, placebo-controlled trial of certolizumab pegol (CDP870) for treatment of Crohn's disease

21 January 2018

1 reference

Certolizumab pegol for the treatment of Crohn's disease

21 January 2018

1 reference

Quantitative measurement and visual assessment of ileal Crohn's disease activity by computed tomography enterography: correlation with endoscopic severity and C reactive protein

21 January 2018

1 reference

Natalizumab for active Crohn's disease

21 January 2018

1 reference

A randomized placebo-controlled trial of a humanized monoclonal antibody to alpha4 integrin in active Crohn's disease.

21 January 2018

1 reference

Natalizumab Induction and Maintenance Therapy for Crohn's Disease

21 January 2018

1 reference

Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease

21 January 2018

1 reference

Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy

21 January 2018

1 reference

Polymeric enteral diets as primary treatment of active Crohn's disease: a prospective steroid controlled trial

21 January 2018

1 reference

Meta-analysis of enteral nutrition as a primary treatment of active crohn's disease

21 January 2018

1 reference

Risk factors for early postoperative recurrence of Crohn's disease

21 January 2018

1 reference

Review article: indication and type of surgery in Crohn's disease

21 January 2018

1 reference

Prospective, randomized trial comparing laparoscopic vs. conventional surgery for refractory ileocolic Crohn's disease

21 January 2018

1 reference

Timing of ileocolonic resection for symptomatic Crohn's disease--the patient's view

21 January 2018

1 reference

Prognosis in Crohn's disease--based on results from a regional patient group from the county of Copenhagen

21 January 2018

1 reference

A controlled double blind study of azathioprine in the management of Crohn's disease

21 January 2018

1 reference

Controlled trial of azathioprine in Crohn's disease.

21 January 2018

1 reference

Double-blind withdrawal trial of azathioprine as maintenance treatment for Crohn's disease

21 January 2018

1 reference

Methotrexate induces clinical and histologic remission in patients with refractory inflammatory bowel disease

21 January 2018

1 reference

Comparison between methotrexate and azathioprine in the treatment of chronic active Crohn's disease: a randomised, investigator-blind study

21 January 2018

1 reference

Efficacy and safety of repeated infliximab infusions for Crohn's disease: 1-year clinical experience

21 January 2018

1 reference

Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease

21 January 2018

1 reference

Low-Dose Cyclosporine for the Treatment of Crohn's Disease

21 January 2018

1 reference

Methotrexate for the Treatment of Crohn's Disease

21 January 2018

1 reference